MovDisordV3, PascalFrancis, Curation, bibRecord, 002A86

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines

Identifieur interne : 002A86 ( PascalFrancis/Curation ); précédent : 002A85; suivant : 002A87

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines

Auteurs : Irene Litvan [États-Unis] ; Jennifer G. Goldman [États-Unis] ; Alexander I. Tröster [États-Unis] ; Ben A. Schmand [Pays-Bas] ; Daniel Weintraub [États-Unis] ; Ronald C. Petersen [États-Unis] ; Brit Mollenhauer [Allemagne] ; Charles H. Adler [États-Unis] ; Karen Marder [États-Unis] ; Caroline H. Williams-Gray [Royaume-Uni] ; Dag Aarsland [Norvège] ; Jaime Kulisevsky [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; David J. Burn [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Murat Emre [Turquie]

Source :

Movement disorders [ 0885-3185 ] ; 2012.

RBID : Pascal:12-0198671

Descripteurs français

Pascal (Inist)
- Déficit cognitif léger, Trouble cognitif, Maladie de Parkinson, Démence, Pathologie du système nerveux, Diagnostic, Force, Cognition.

English descriptors

KwdEn :
- Cognition, Cognitive disorder, Dementia, Diagnosis, Force, Nervous system diseases, Parkinson disease, mild cognitive impairment.

Abstract

Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long-term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 27`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines`
A11	`01`	`1`		`@1 LITVAN (Irene)`
A11	`02`	`1`		`@1 GOLDMAN (Jennifer G.)`
A11	`03`	`1`		`@1 TRÖSTER (Alexander I.)`
A11	`04`	`1`		`@1 SCHMAND (Ben A.)`
A11	`05`	`1`		`@1 WEINTRAUB (Daniel)`
A11	`06`	`1`		`@1 PETERSEN (Ronald C.)`
A11	`07`	`1`		`@1 MOLLENHAUER (Brit)`
A11	`08`	`1`		`@1 ADLER (Charles H.)`
A11	`09`	`1`		`@1 MARDER (Karen)`
A11	`10`	`1`		`@1 WILLIAMS-GRAY (Caroline H.)`
A11	`11`	`1`		`@1 AARSLAND (Dag)`
A11	`12`	`1`		`@1 KULISEVSKY (Jaime)`
A11	`13`	`1`		`@1 RODRIGUEZ-OROZ (Maria C.)`
A11	`14`	`1`		`@1 BURN (David J.)`
A11	`15`	`1`		`@1 BARKER (Roger A.)`
A11	`16`	`1`		`@1 EMRE (Murat)`
A14	`01`			`@1 Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA; and Movement Disorders Program, Frazier Rehab Neuroscience Institute @2 Louisville, Kentucky @3 USA @Z 1 aut.`
A14	`02`			`@1 Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 2 aut.`
A14	`03`			`@1 Department of Neurology, University of North Carolina at Chapel Hill School of Medicine @2 Chapel Hill, North Carolina @3 USA @Z 3 aut.`
A14	`04`			`@1 Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands; and Department of Neurology, Academic Medical Center @2 Amsterdam @3 NLD @Z 4 aut.`
A14	`05`			`@1 Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine Philadelphia @2 Pennsylvania @3 USA @Z 5 aut.`
A14	`06`			`@1 Parkinson's Disease and Mental Illness Research, Education and Clinical Centers, Philadelphia Veterans Affairs Medical Center @2 Philadelphia, Pennsylvania @3 USA @Z 5 aut.`
A14	`07`			`@1 Mayo Alzheimer's Disease Research Center, Mayo Clinic @2 Rochester, Minnesota @3 USA @Z 6 aut.`
A14	`08`			`@1 Paracelsus-Elena-Klinik, Kassel, Germany; and Georg-August University Goettingen @2 Goettingen @3 DEU @Z 7 aut.`
A14	`09`			`@1 Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic @2 Scottsdale, Arizona @3 USA @Z 8 aut.`
A14	`10`			`@1 Taub Institute on Alzheimers Disease and the Aging Brain, Department of Neurology, New York Presbyterian Hospital, Columbia University Medical Center @2 NY, New York @3 USA @Z 9 aut.`
A14	`11`			`@1 Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge @2 Cambridge @3 GBR @Z 10 aut. @Z 15 aut.`
A14	`12`			`@1 Karolinska Institute, Stockholm, Center for Age-Related Medicine, Stavanger University Hospital, Stockholm, Sweden; and Akershus University Hospital/University of Oslo @2 Oslo @3 NOR @Z 11 aut.`
A14	`13`			`@1 Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona @2 Barcelona @3 ESP @Z 12 aut.`
A14	`14`			`@1 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas @2 Barcelona @3 ESP @Z 12 aut.`
A14	`15`			`@1 Department of Neurology, Hospital Donostia, Donostia, Spain; Neuroscience Unit, BioDonostia Research Institute, San Sebatian @2 San Sebatian @3 ESP @Z 13 aut.`
A14	`16`			`@1 Ikerbasque, Basque Foundation for Science, Bilbao, Bilbao, Span; and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas @2 Barcelona @3 ESP @Z 13 aut.`
A14	`17`			`@1 Institute for Aging and Health, Newcastle University @2 Newcastle upon Tyne @3 GBR @Z 14 aut.`
A14	`18`			`@1 Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University @2 Istanbul @3 TUR @Z 16 aut.`
A20				`@1 349-356`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000506923350060`
A44				`@0 0000 @1 © 2012 INIST-CNRS. All rights reserved.`
A45				`@0 61 ref.`
A47	`01`	`1`		`@0 12-0198671`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long-term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Déficit cognitif léger @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 mild cognitive impairment @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Disturbio cognitivo ligero @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Trouble cognitif @5 02`
C03	`02`	`X`	`ENG`	`@0 Cognitive disorder @5 02`
C03	`02`	`X`	`SPA`	`@0 Trastorno cognitivo @5 02`
C03	`03`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 03`
C03	`04`	`X`	`FRE`	`@0 Démence @5 04`
C03	`04`	`X`	`ENG`	`@0 Dementia @5 04`
C03	`04`	`X`	`SPA`	`@0 Demencia @5 04`
C03	`05`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 05`
C03	`05`	`X`	`ENG`	`@0 Nervous system diseases @5 05`
C03	`05`	`X`	`SPA`	`@0 Sistema nervioso patología @5 05`
C03	`06`	`X`	`FRE`	`@0 Diagnostic @5 09`
C03	`06`	`X`	`ENG`	`@0 Diagnosis @5 09`
C03	`06`	`X`	`SPA`	`@0 Diagnóstico @5 09`
C03	`07`	`X`	`FRE`	`@0 Force @5 10`
C03	`07`	`X`	`ENG`	`@0 Force @5 10`
C03	`07`	`X`	`SPA`	`@0 Fuerza @5 10`
C03	`08`	`X`	`FRE`	`@0 Cognition @5 11`
C03	`08`	`X`	`ENG`	`@0 Cognition @5 11`
C03	`08`	`X`	`SPA`	`@0 Cognición @5 11`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 156`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000228

Links to Exploration step

Pascal:12-0198671

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines</title>
<author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA; and Movement Disorders Program, Frazier Rehab Neuroscience Institute</s1>
<s2>Louisville, Kentucky</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Goldman, Jennifer G" sort="Goldman, Jennifer G" uniqKey="Goldman J" first="Jennifer G." last="Goldman">Jennifer G. Goldman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Troster, Alexander I" sort="Troster, Alexander I" uniqKey="Troster A" first="Alexander I." last="Tröster">Alexander I. Tröster</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine</s1>
<s2>Chapel Hill, North Carolina</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Schmand, Ben A" sort="Schmand, Ben A" uniqKey="Schmand B" first="Ben A." last="Schmand">Ben A. Schmand</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands; and Department of Neurology, Academic Medical Center</s1>
<s2>Amsterdam</s2>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine Philadelphia</s1>
<s2>Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Parkinson's Disease and Mental Illness Research, Education and Clinical Centers, Philadelphia Veterans Affairs Medical Center</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Petersen, Ronald C" sort="Petersen, Ronald C" uniqKey="Petersen R" first="Ronald C." last="Petersen">Ronald C. Petersen</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Mayo Alzheimer's Disease Research Center, Mayo Clinic</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mollenhauer, Brit" sort="Mollenhauer, Brit" uniqKey="Mollenhauer B" first="Brit" last="Mollenhauer">Brit Mollenhauer</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Paracelsus-Elena-Klinik, Kassel, Germany; and Georg-August University Goettingen</s1>
<s2>Goettingen</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic</s1>
<s2>Scottsdale, Arizona</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Marder, Karen" sort="Marder, Karen" uniqKey="Marder K" first="Karen" last="Marder">Karen Marder</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Taub Institute on Alzheimers Disease and the Aging Brain, Department of Neurology, New York Presbyterian Hospital, Columbia University Medical Center</s1>
<s2>NY, New York</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Williams Gray, Caroline H" sort="Williams Gray, Caroline H" uniqKey="Williams Gray C" first="Caroline H." last="Williams-Gray">Caroline H. Williams-Gray</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Karolinska Institute, Stockholm, Center for Age-Related Medicine, Stavanger University Hospital, Stockholm, Sweden; and Akershus University Hospital/University of Oslo</s1>
<s2>Oslo</s2>
<s3>NOR</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Norvège</country>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Maria C" sort="Rodriguez Oroz, Maria C" uniqKey="Rodriguez Oroz M" first="Maria C." last="Rodriguez-Oroz">Maria C. Rodriguez-Oroz</name>
<affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Department of Neurology, Hospital Donostia, Donostia, Spain; Neuroscience Unit, BioDonostia Research Institute, San Sebatian</s1>
<s2>San Sebatian</s2>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Ikerbasque, Basque Foundation for Science, Bilbao, Bilbao, Span; and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Institute for Aging and Health, Newcastle University</s1>
<s2>Newcastle upon Tyne</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University</s1>
<s2>Istanbul</s2>
<s3>TUR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Turquie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0198671</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0198671 INIST</idno>
<idno type="RBID">Pascal:12-0198671</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000228</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002A86</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines</title>
<author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA; and Movement Disorders Program, Frazier Rehab Neuroscience Institute</s1>
<s2>Louisville, Kentucky</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Goldman, Jennifer G" sort="Goldman, Jennifer G" uniqKey="Goldman J" first="Jennifer G." last="Goldman">Jennifer G. Goldman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Troster, Alexander I" sort="Troster, Alexander I" uniqKey="Troster A" first="Alexander I." last="Tröster">Alexander I. Tröster</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine</s1>
<s2>Chapel Hill, North Carolina</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Schmand, Ben A" sort="Schmand, Ben A" uniqKey="Schmand B" first="Ben A." last="Schmand">Ben A. Schmand</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands; and Department of Neurology, Academic Medical Center</s1>
<s2>Amsterdam</s2>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine Philadelphia</s1>
<s2>Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Parkinson's Disease and Mental Illness Research, Education and Clinical Centers, Philadelphia Veterans Affairs Medical Center</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Petersen, Ronald C" sort="Petersen, Ronald C" uniqKey="Petersen R" first="Ronald C." last="Petersen">Ronald C. Petersen</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Mayo Alzheimer's Disease Research Center, Mayo Clinic</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mollenhauer, Brit" sort="Mollenhauer, Brit" uniqKey="Mollenhauer B" first="Brit" last="Mollenhauer">Brit Mollenhauer</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Paracelsus-Elena-Klinik, Kassel, Germany; and Georg-August University Goettingen</s1>
<s2>Goettingen</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic</s1>
<s2>Scottsdale, Arizona</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Marder, Karen" sort="Marder, Karen" uniqKey="Marder K" first="Karen" last="Marder">Karen Marder</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Taub Institute on Alzheimers Disease and the Aging Brain, Department of Neurology, New York Presbyterian Hospital, Columbia University Medical Center</s1>
<s2>NY, New York</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Williams Gray, Caroline H" sort="Williams Gray, Caroline H" uniqKey="Williams Gray C" first="Caroline H." last="Williams-Gray">Caroline H. Williams-Gray</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Karolinska Institute, Stockholm, Center for Age-Related Medicine, Stavanger University Hospital, Stockholm, Sweden; and Akershus University Hospital/University of Oslo</s1>
<s2>Oslo</s2>
<s3>NOR</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Norvège</country>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, Maria C" sort="Rodriguez Oroz, Maria C" uniqKey="Rodriguez Oroz M" first="Maria C." last="Rodriguez-Oroz">Maria C. Rodriguez-Oroz</name>
<affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Department of Neurology, Hospital Donostia, Donostia, Spain; Neuroscience Unit, BioDonostia Research Institute, San Sebatian</s1>
<s2>San Sebatian</s2>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Ikerbasque, Basque Foundation for Science, Bilbao, Bilbao, Span; and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Institute for Aging and Health, Newcastle University</s1>
<s2>Newcastle upon Tyne</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University</s1>
<s2>Istanbul</s2>
<s3>TUR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Turquie</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognition</term>
<term>Cognitive disorder</term>
<term>Dementia</term>
<term>Diagnosis</term>
<term>Force</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>mild cognitive impairment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Déficit cognitif léger</term>
<term>Trouble cognitif</term>
<term>Maladie de Parkinson</term>
<term>Démence</term>
<term>Pathologie du   système nerveux</term>
<term>Diagnostic</term>
<term>Force</term>
<term>Cognition</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long-term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>27</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LITVAN (Irene)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GOLDMAN (Jennifer G.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>TRÖSTER (Alexander I.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SCHMAND (Ben A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>WEINTRAUB (Daniel)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>PETERSEN (Ronald C.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>MOLLENHAUER (Brit)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>ADLER (Charles H.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>MARDER (Karen)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>WILLIAMS-GRAY (Caroline H.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>AARSLAND (Dag)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>KULISEVSKY (Jaime)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>RODRIGUEZ-OROZ (Maria C.)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>BURN (David J.)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>BARKER (Roger A.)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>EMRE (Murat)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA; and Movement Disorders Program, Frazier Rehab Neuroscience Institute</s1>
<s2>Louisville, Kentucky</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine</s1>
<s2>Chapel Hill, North Carolina</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands; and Department of Neurology, Academic Medical Center</s1>
<s2>Amsterdam</s2>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine Philadelphia</s1>
<s2>Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Parkinson's Disease and Mental Illness Research, Education and Clinical Centers, Philadelphia Veterans Affairs Medical Center</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Mayo Alzheimer's Disease Research Center, Mayo Clinic</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Paracelsus-Elena-Klinik, Kassel, Germany; and Georg-August University Goettingen</s1>
<s2>Goettingen</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic</s1>
<s2>Scottsdale, Arizona</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Taub Institute on Alzheimers Disease and the Aging Brain, Department of Neurology, New York Presbyterian Hospital, Columbia University Medical Center</s1>
<s2>NY, New York</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Karolinska Institute, Stockholm, Center for Age-Related Medicine, Stavanger University Hospital, Stockholm, Sweden; and Akershus University Hospital/University of Oslo</s1>
<s2>Oslo</s2>
<s3>NOR</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>Department of Neurology, Hospital Donostia, Donostia, Spain; Neuroscience Unit, BioDonostia Research Institute, San Sebatian</s1>
<s2>San Sebatian</s2>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>Ikerbasque, Basque Foundation for Science, Bilbao, Bilbao, Span; and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Institute for Aging and Health, Newcastle University</s1>
<s2>Newcastle upon Tyne</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="18"><s1>Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University</s1>
<s2>Istanbul</s2>
<s3>TUR</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA20><s1>349-356</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000506923350060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>61 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0198671</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long-term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Déficit cognitif léger</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>mild cognitive impairment</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Disturbio cognitivo ligero</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Trouble cognitif</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cognitive disorder</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Trastorno cognitivo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Démence</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dementia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Demencia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Force</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Force</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Fuerza</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Cognition</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Cognition</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Cognición</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>156</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A86 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002A86 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:12-0198671
   |texte=   Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri